HAL vs PHAT · P/E 9.3, $19.05B cap vs rev $55.3M
Halliburton Company (HAL) versus Phathom Pharmaceuticals Inc (PHAT) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported PHAT revenue for 2024-12-31 was $55.3M. Net income was -$334.3M. Revenue was up 8001.5% from 2023-12-31 to 2024-12-31. PHAT currently screens at market cap $622.7M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. PHAT currently screens at market cap $622.7M.
Not investment advice. Open the HAL and PHAT stock pages for the full models.
Not investment advice.